
Lupin Launches Triple-Combination Formoflo-G MDI for COPD Treatment in India
Lupin Limited has launched Formoflo-G MDI in India following approval from the Drug Controller General

Lupin Limited has launched Formoflo-G MDI in India following approval from the Drug Controller General

Lupin Limited has received final approval from the United States Food and Drug Administration (US

Global pharmaceutical company Lupin Limited has received approval from the US Food and Drug Administration

Lupin Limited has received approval from the United States Food and Drug Administration (US FDA)

Lupin Limited (Lupin), a global pharmaceutical company, has been recognised among India’s Best Employers in

Global pharmaceutical company Lupin Limited has been recognised among the TIME and Statista World’s Most

Global pharmaceutical company Lupin Limited has received approval from the European Medicines Agency (EMA) to

Lupin Limited has received tentative approval from the US Food and Drug Administration (FDA) for

Lupin Limited has expanded its cardiovascular portfolio in the United States with the commercial launch

Global pharmaceutical company Lupin Limited has entered into a strategic collaboration with LABORATORIOS ERN SA